Description:

E1105 Quality of Life Assessment Form NCT00520975 First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=17363D95-6129-3B27-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=17363D95-6129-3B27-E044-0003BA3F9857

Keywords:

Clinical Trial

Quality of Life

Breast Neoplasms

Versions (3) ▾

8/26/12
1/9/15
6/16/15

Uploaded on:

June 16, 2015

DOI:

No DOI assigned. To request one please log in.

License:

Creative Commons BY-NC 3.0 Legacy

Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

E1105 Quality of Life Assessment Form NCT00520975

Details

INSTRUCTIONS: After patient is off treatment, complete this form for each required follow-up report period (see forms submission schedule).

StudyEvent: E1105 Quality of Life Assessment Form
1. INSTRUCTIONS: After patient is off treatment, complete this form for each required follow-up report period (see forms submission schedule).

Header

ECOG Protocol Number

ECOG Patient ID

DCI Name

Registration Step

Patient demographics

ECOG Protocol Number

Patient Initials (Last, First)

ECOG Patient ID

Participating Group Protocol Number

Institution/Affiliate

Participating Group Patient ID

Data amendment

Please mark an 'X' if data have been amended (Please circle amended items in red)

Date data amended (M D Y)

Back to the top of the page

Similar models

Show recommended models